These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38388422)

  • 1. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
    Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
    BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous bilateral non-Hodgkin's diffuse large B-cell lymphoma of the breast and left breast invasive ductal carcinoma: a case report and review of literature.
    Liu W; Zhu H; Zhou X
    Int J Clin Exp Pathol; 2014; 7(10):7042-8. PubMed ID: 25400793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral synchronous breast carcinomas followed by a metastasis to the gallbladder: a case report.
    Zagouri F; Sergentanis TN; Koulocheri D; Nonni A; Bousiotou A; Domeyer P; Michalopoulos NV; Dardamanis D; Konstadoulakis MM; Zografos GC
    World J Surg Oncol; 2007 Sep; 5():101. PubMed ID: 17848197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
    Paolino G; Panetta C; Didona D; Donati M; Donati P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer.
    Chen HR; Wu YT; Yu QB; Yang YY; Wei YX; Li HY; Wu KN; Kong LQ
    World J Surg Oncol; 2017 Oct; 15(1):189. PubMed ID: 29052527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
    Porter K; Rosenzweig MQ
    J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
    [No Abstract]   [Full Text] [Related]  

  • 7. Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy.
    Wong H; Lau S; Cheung P; Wong TT; Parker A; Yau T; Epstein RJ
    BMC Cancer; 2014 Nov; 14():826. PubMed ID: 25385074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of quadruple primary malignancies including breast, tongue, and thyroid cancers and osteosarcoma in a young female without karyotype abnormality.
    Kousaka J; Fujii K; Yorozuya K; Mouri Y; Yoshida M; Nakano S; Fukutomi T; Takahashi E; Yokoi T
    Breast Cancer; 2014 Jul; 21(4):500-3. PubMed ID: 21562838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of the ultrasound imaging of breast cancer and the expression of molecular biological indexes.
    Xu J; Li F; Chang F
    Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1425-1430. PubMed ID: 29043992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDX2-positive breast cancer presented with axillary lymph node metastases: A case report.
    Hoshina H; Takei H; Sakatani T; Naito Z
    Cancer Treat Res Commun; 2021; 26():100300. PubMed ID: 33421821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bax protein expression in DCIS of the breast in relation to invasive ductal carcinoma and other molecular markers.
    Rehman S; Crow J; Revell PA
    Pathol Oncol Res; 2000; 6(4):256-63. PubMed ID: 11173657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordant clear cell "mesonephric" carcinoma of the bladder and lung adenocarcinoma with clear cell features - multiple primaries versus metastatic neoplasms: a case report.
    Jassim SH; Khiyami A; Nguyen JK; Ganesan S; Tomashefski J; Sawady J
    J Med Case Rep; 2017 May; 11(1):133. PubMed ID: 28494807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Late metastases from breast cancer--report of two cases].
    Gabrovski N; Poptodorov G; Velinov N; Gabrovski S
    Khirurgiia (Sofiia); 2010; (1):62-6. PubMed ID: 21972709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance: A case report.
    Jiang Y; Shou L; Guo Q; Bao Y; Xu X; An S; Lu J
    Medicine (Baltimore); 2021 Aug; 100(32):e26911. PubMed ID: 34397927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer.
    Wong H; Lau S; Leung R; Chiu J; Cheung P; Wong TT; Liang R; Epstein RJ; Yau T
    Med Oncol; 2012 Sep; 29(3):1536-42. PubMed ID: 21983862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary Duct Carcinoma and Invasive Ductal Carcinoma of the Breast: A Comparative Immunohistochemical Study.
    Jalaly JB; Sanati S; Chernock RD; Dibe DG; El-Mofty SK
    Head Neck Pathol; 2018 Dec; 12(4):488-492. PubMed ID: 29302899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary mucosa-associated lymphoid tissue lymphoma concurrent with lung squamous cell carcinoma: a case report and literature review].
    Zhang CS; Yang XR; Ding W; Lu XY; Shen L; Zhao YF
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Dec; 43(12):1071-1076. PubMed ID: 33333642
    [No Abstract]   [Full Text] [Related]  

  • 18. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
    Curigliano G; Criscitiello C
    J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
    Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.